AG
TXG icon

Algert Global’s 10x Genomics TXG Stock Holding History

Algert Global’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.13M Sell
147,310
-242,970
-62% -$4.86M 0.05% 586
2025
Q4 		$6.37M Sell
390,280
-184,160
-32% -$2.78M 0.1% 348
2025
Q3 		$6.71M Sell
574,440
-705,428
-55% -$9.2M 0.11% 311
2025
Q2 		$14.8M Buy
1,279,868
+826,581
+182% +$7.53M 0.31% 51
2025
Q1 		$3.96M Sell
453,287
-207,333
-31% -$2.61M 0.1% 353
2024
Q4 		$9.49M Buy
660,620
+289,662
+78% +$4.57M 0.22% 122
2024
Q3 		$8.38M Buy
370,958
+252,994
+214% +$5.23M 0.23% 118
2024
Q2 		$2.29M Buy
117,964
+33,364
+39% +$874K 0.08% 425
2024
Q1 		$3.17M Buy
84,600
+59,360
+235% +$2.61M 0.12% 276
2023
Q4 		$1.41M Buy
25,240
+4,850
+24% +$211K 0.06% 523
2023
Q3 		$841K Sell
20,390
-21,721
-52% -$1.13M 0.04% 605
2023
Q2 		$2.35M Sell
42,111
-9,043
-18% -$489K 0.1% 343
2023
Q1 		$2.85M Buy
+51,154
New +$2.39M 0.13% 230

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Algert Global's TXG Position: Q1 2026 in Review

Algert Global reduced its 10x Genomics (TXG) stake by 62% in Q1 2026, selling an estimated $4.86M and leaving 147,310 shares worth $3.13M. The position accounts for 0.05% of the portfolio, ranked #586.

Algert Global first reported a position in TXG in Q1 2023 and has held it in 13 quarters since. The position peaked at $14.8M in Q2 2025. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Algert Global held 147,310 shares of 10x Genomics worth $3.13M as of Q1 2026.
  • Algert Global sold 242,970 10x Genomics shares in Q1 2026, an estimated $4.86M.
  • 10x Genomics made up 0.05% of Algert Global's portfolio in Q1 2026, its #586 holding.
  • Algert Global first reported a position in 10x Genomics in Q1 2023 and has held it in 13 quarters since.
  • Algert Global's 10x Genomics position peaked at $14.8M in Q2 2025.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.